APA (7th ed.) Citation

K, L., G, X., Z, C., M, D., & Z, Q. (2026). Interleukin-1α (IL-1α) in pancreatic ductal adenocarcinoma: Implications for immunotherapy and molecular biomarkers. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. https://doi.org/10.1007/s12094-026-04325-5

Chicago Style (17th ed.) Citation

K, Ling, Xie G, Chen Z, Da M, and Qiu Z. "Interleukin-1α (IL-1α) in Pancreatic Ductal Adenocarcinoma: Implications for Immunotherapy and Molecular Biomarkers." Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2026. https://doi.org/10.1007/s12094-026-04325-5.

MLA (9th ed.) Citation

K, Ling, et al. "Interleukin-1α (IL-1α) in Pancreatic Ductal Adenocarcinoma: Implications for Immunotherapy and Molecular Biomarkers." Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2026, https://doi.org/10.1007/s12094-026-04325-5.